FDA grants Breakthrough Device designation to Natera MCED assay
Natera said the U.S. FDA granted Breakthrough Device designation to its multi-cancer early detection (MCED) assay.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.